OptiNose AS Bi-Directional Drug Delivery Technology Wins Innovation Award for Potential Benefits of Nose to Brain Application

OptiNose Inc. announced that the Company has recently won the Oslo regional finals of the DnB NOR Innovation Award for its novel, bi-directional nasal drug delivery technology. The annual competition arranged by the Norwegian bank DnB, Norway’s largest financial services group, recognizes innovative companies for the best business ideas of the year. Winning ideas build on new knowledge, or use existing knowledge in an innovative way. The panel emphasizes that winning ideas must have the potential for commercial value, societal benefit and the opportunity for economic savings. Additionally, companies need to exhibit a development plan for the realization of the idea.